mtor key modulator ageing age-related disease abstract experts biology ageing pharmacological interventions slow ageing matter leading target interventions nutrient response pathway defined mechanistic target rapamycin mtor inhibition pathway extends lifespan model organisms confers protection growing list age-related pathologies characterized inhibitors pathway clinically approved development adverse side effects preclude healthy individuals drugs target mtor pathway day widely slow ageing reduce age-related pathologies humans 
